Ryan Morin

Researcher
  • Canada's Michael Smith Genome Sciences Centre
  • Simon Fraser University
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Blood Cancers

    Modeling lymphoma evolution and clinical trajectory using multiomics

    It’s their fifth cycle of funding for researchers at the BC Cancer Centre for Lymphoid Cancer who are part of the renewal of a coveted Terry Fox New Frontiers Program Projects Grant, following t...

    Read More
  • Completed
    Blood Cancers

    Overcoming treatment failure in lymphoid cancers

    TFRI’s prolific lymphoid cancer team began their research with a simple question: “Why do two-thirds of lymphoma patients recover, while the remainder does not?” A decade later their...

    Read More
  • Completed
    Blood Cancers

    Exploring clonal evolution in non-Hodgkin lymphomas using serial tumour sampling and liquid biopsies

    Working at the BC Genome Sciences Centre a decade ago, Dr. Ryan Morin didn’t intend to become a cancer researcher. Yet today, following the path he began as a graduate student, he is using his e...

    Read More
  • Completed
    Rare Cancers

    Genomics of forme fruste tumours: new vistas on cancer biology and treatment

    Studying “rare and unusual” forme fruste tumours may not seem like the most obvious way to advance cancer research, but pathologist Dr. David Huntsman’s work is revolutionizing the w...

    Read More

Related News & Events

  • Research Highlight|October 21, 2021

    Lymphoma team publishes two papers on diffuse large B-cell lymphoma in major journal

    Both papers help to better understand diffuse large B-cell lymphoma (DLBCL), a heterogeneous form of non-Hodgkin lymphoma that has an average five-yea...

  • Research Highlight|June 03, 2019

    EZH2 inhibitors could make immunotherapies more effective for a subset of patients with diffuse large B-cell lymphoma

    A study by a group of BC-based scientists partly funded by the TFRI has discovered mutations responsible for changes in expression of major histocompa...

  • Research Highlight|May 15, 2019

    Team identifies new classification system for Burkitt’s Lymphoma and opens door for more precise treatments

    A group of scientists partly funded by the Terry Fox Research Institute has discovered a better way to classify Burkitt’s lymphoma (BL), a rare type o...

  • Press Release|August 19, 2015

    TFRI BC researchers aim to improve treatment, diagnostics for leukemia and lymphoma

    Vancouver, BC --Terry Fox’s research legacy continues in British Columbia 35 years after he set out on his Marathon of Hope. Two local cancer research...

  • All News & Events